Learn why timing and muscle health are vital when using GLP-1 therapy for weight management during and after breast cancer ...

In recent years, nanoplastic and microplastic particles (NMPs) have emerged as substantial threats to human health, particularly as endocrine disruptors. The endocrine system is especially vulnerable ...

Endocrine therapy remains a backbone of adjuvant therapy for women with hormone receptor–positive early-stage breast cancer. Numerous studies have demonstrated the benefit of ovarian function ...

Women with breast cancer treated with complementary and alternative medicines have significantly worse survival than those receiving traditional therapies, likely due to underutilization of proven ...

Surgery performed with its focus on one or more of the endocrine organs is referred to as endocrine surgery. The endocrine organs are glands located throughout the body, which secrete hormones that ...

In patients with regional lymph node status 0-1, HER+ HER– early breast cancer (n = 2,290), 5-year invasive disease-free survival was 92.6% (95% CI, 90.8 to 94.0) with recurrence score (RS) 12-25 and ...

As a synthetic decapeptide structurally derived from gonadotropin-releasing hormone (GnRH), Triptorelin has long attracted research interest due to its unusually paradoxical signalling profile.